Related Experiment Videos
Pharmacologic management of obstructive lung disease. Current perspectives
The American Journal of Medicine
|November 14, 1986
Summary
Recent advances in obstructive lung disease pharmacotherapy include new drug classes like steroids and anticholinergic agents. Effective management requires personalized treatment, aiming for optimal airway function while minimizing steroid use and side effects.
Area of Science:
- Pulmonology
- Pharmacology
- Respiratory Medicine
Background:
- Obstructive lung disease pharmacotherapy has seen significant advancements.
- Improvements include enhanced adrenergic and methylxanthine drugs.
- New drug classes such as steroids, cromolyn, and anticholinergic agents have been introduced.
Purpose of the Study:
- To review the current pharmacotherapy for obstructive lung disease.
- To outline key principles in managing airways disease.
- To discuss the efficacy and adverse effects of available pharmacologic agents.
Main Methods:
- Review of recent developments in pharmacologic agents for obstructive lung disease.
- Analysis of management principles for airways disease.
- Discussion of drug combinations and individualized treatment strategies.
Main Results:
- Pharmacotherapy has improved both quantitatively and qualitatively.
- New drug classes offer expanded treatment options.
- Individualized treatment plans are crucial for effective management.
Conclusions:
- Modern pharmacotherapy provides improved options for obstructive lung disease.
- Management emphasizes achieving near-normal airway function.
- Minimizing long-term, high-dose corticosteroid use is a key principle.